Systemic α₂-agonist use and lower hazard of glaucoma compared with β-blockers: a cohort study. uri icon

authors

  • Abboud, Ibrahim
  • Khudari, Amin Z
  • Abdelaal, Abdelaziz
  • Almobayed, Amr
  • Al'Aref, Subhi J
  • Myers, Jonathan S
  • Lee, Richard K
  • Abdelrahman M. Elhusseiny

publication date

  • May 7, 2026